Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xi Ling

Showing results (491-500 of 503) with videos related to

Pageof 51
Sort By:
International Journal of Epidemiology|June 17, 2025
Cohort Profile: Preconception Reproductive Health and Birth Outcome Cohort (PREBIC) in Chongqing, ChinaHuan Yang, Wenzheng Zhou, Niya Zhou, et al.
The Lancet. Respiratory Medicine|May 23, 2022
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJing-Xin Li, Shi-Po Wu, Xi-Ling Guo, et al.
Signal Transduction and Targeted Therapy|July 16, 2021
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trialsFan-Yue Meng, Fan Gao, Si-Yue Jia, et al.
Nature Nanotechnology|February 24, 2026
Tailorable multiferroic tunnel junctions from all-van der Waals multilayer stackingTi Xie, Qinqin Wang, Hongrui Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 11, 2020
Deep-Learning-Enabled Fast Optical Identification and Characterization of 2D MaterialsBingnan Han, Yuxuan Lin, Yafang Yang, et al.
Nano Letters|November 9, 2020
Modulation Doping via a Two-Dimensional Atomic Crystalline AcceptorYiping Wang, Jesse Balgley, Eli Gerber, et al.
The Lancet. Respiratory Medicine|March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Hui Zheng, Bu-Sen Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2011
A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmissionChang-jun Bao, Xi-ling Guo, Xian Qi, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
National Science Review|October 22, 2021
A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2Li Zhang, Lei Cao, Xing-Su Gao, et al.
Pageof 51

Showing results (491-500 of 503) with videos related to

Sort By:
Pageof 51
International Journal of Epidemiology|June 17, 2025
Cohort Profile: Preconception Reproductive Health and Birth Outcome Cohort (PREBIC) in Chongqing, ChinaHuan Yang, Wenzheng Zhou, Niya Zhou, et al.
The Lancet. Respiratory Medicine|May 23, 2022
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJing-Xin Li, Shi-Po Wu, Xi-Ling Guo, et al.
Signal Transduction and Targeted Therapy|July 16, 2021
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trialsFan-Yue Meng, Fan Gao, Si-Yue Jia, et al.
Nature Nanotechnology|February 24, 2026
Tailorable multiferroic tunnel junctions from all-van der Waals multilayer stackingTi Xie, Qinqin Wang, Hongrui Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 11, 2020
Deep-Learning-Enabled Fast Optical Identification and Characterization of 2D MaterialsBingnan Han, Yuxuan Lin, Yafang Yang, et al.
Nano Letters|November 9, 2020
Modulation Doping via a Two-Dimensional Atomic Crystalline AcceptorYiping Wang, Jesse Balgley, Eli Gerber, et al.
The Lancet. Respiratory Medicine|March 10, 2023
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trialRong Tang, Hui Zheng, Bu-Sen Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2011
A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmissionChang-jun Bao, Xi-ling Guo, Xian Qi, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
National Science Review|October 22, 2021
A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2Li Zhang, Lei Cao, Xing-Su Gao, et al.
Pageof 51